Neuralink's "Blindsight" device, developed by Elon Musk's company, aims to restore vision for blind individuals.

Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation.

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain implant tech as a world-changing solution for people with vision loss.

Elon Musk's brain-chip startup Neuralink announces its experimental implant can restore vision, receives US FDA 'breakthrough device' designation.

Elon Musk's Blindsight brain implant has achieved a major milestone. It's now being worn by Geordi La Forge. No wait, it's actually been awarded Breakthrough Device Designation by the FDA. But to celebrate, Musk evoked the famously vision-enhanced Star Trek character in an X post.

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain implant tech as a world-changing solution for people with vision loss.

T-Mobile is making a bold move into AI in 2024, partnering with OpenAI to revolutionize how it handles customer support.

Its latest device, or implant, named ‘Blindsight’ can restore vision to the blind, claims Elon Musk. What’s even more fascinating is the fact that the US Food and Drug Administration (FDA) has designated Neuralink's experimental Blindsight implant as a "breakthrough device.

Elon Musk’s Neuralink has recently achieved a significant milestone with its experimental vision-restoring implant, Blindsight. The U.S. Food and Drug Administration (FDA) has granted the device a "Breakthrough Device" designation,